DekaBank Deutsche Girozentrale’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Sell |
24,000
-2,690
| -10% | -$38.4K | ﹤0.01% | 1039 |
|
|
2025
Q1 | $360K | Buy |
26,690
+2,690
| +11% | +$36.3K | ﹤0.01% | 1019 |
|
|
2024
Q4 | $300K | Hold |
24,000
| – | – | ﹤0.01% | 1087 |
|
|
2024
Q3 | $317K | Hold |
24,000
| – | – | ﹤0.01% | 1089 |
|
|
2024
Q2 | $317K | Sell |
24,000
-2,690
| -10% | -$35.5K | ﹤0.01% | 1080 |
|
|
2024
Q1 | $360K | Hold |
26,690
| – | – | ﹤0.01% | 1060 |
|
|
2023
Q4 | $370K | Sell |
26,690
-23,310
| -47% | -$323K | ﹤0.01% | 1099 |
|
|
2023
Q3 | $648K | Hold |
50,000
| – | – | ﹤0.01% | 961 |
|
|
2023
Q2 | $938K | Buy |
50,000
+27,000
| +117% | +$507K | ﹤0.01% | 901 |
|
|
2023
Q1 | $329K | Hold |
23,000
| – | – | ﹤0.01% | 1106 |
|
|
2022
Q4 | $433K | Hold |
23,000
| – | – | ﹤0.01% | 1068 |
|
|
2022
Q3 | $795K | Buy |
+23,000
| New | +$795K | ﹤0.01% | 934 |
|
|
2022
Q1 | – | Sell |
-18,000
| Closed | -$647K | – | 1444 |
|
|
2021
Q4 | $647K | Buy |
+18,000
| New | +$647K | ﹤0.01% | 1038 |
|